Wednesday, October 13, 2021 – Thursday, October 14, 2021, @homeoffice.
It was time again for a “Status of the Project” meeting. This time the consortium partners came together because we have been working on our objectives for 30 months. In order to enable our colleagues from overseas to participate, the online conference took place in the afternoon. On the first day, the status of each work package was also discussed. With a few corona-related exceptions, most of our work packages continue to be on track. Very good news.
On the following second day, scientific knowledge from the work packages was shared. We particularly want to highlight two scientific lectures: Stefan M. Kohlbacher (UniVie) and Miroslav Savic (UniBeo) contributed to this successful meeting with their interesting talks. We would like to express our special thanks to them.
As always, we would like to thank all of our consortium partners for their great commitment to our common goal: providing novel validated integrated tools for improving the preclinical prediction of adverse effects of pharmaceuticals on the nervous system and thus help to de-risk drug candidates earlier in the R&D phases.
